neobookRx

Post-Streptococcal Glomerulonephritis

Description Diagnostic criteria General and supportive measures Medicine treatment Referral ICD-10 code:  N00.9 DESCRIPTION Acute post-streptococcal glomerulonephritis (APSGN) is a disorder of the kidneys caused by an immunological response of the kidney to nephritogenic strains of streptococci. It develops one to three weeks after a streptococcal throat or skin infection. Immune complexes a

Description

Diagnostic criteria

General and supportive measures

Medicine treatment

Referral


ICD-10 code: N00.9

DESCRIPTION

Acute post-streptococcal glomerulonephritis (APSGN) is a disorder of the kidneys caused by an immunological response of the kidney to nephritogenic strains of streptococci. It develops one to three weeks after a streptococcal throat or skin infection. Immune complexes are deposited in the glomerular basement membrane and/or mesangium of the glomeruli.

DIAGNOSTIC CRITERIA

Clinical

  • Occurs predominantly in children 3–12 years old.
  • Presents approximately 1 week after streptococcal pharyngitis OR approximately 3 weeks after skin infection (impetigo).
  • Characteristic features include:
    • facial or generalised oedema,
    • painless macroscopic haematuria (smoky or tea coloured urine),
    • oliguria, and
    • hypertension.

Special investigations to confirm APSGN

Urine analysis
Macroscopic appearance smoky, brown, bloody
Urine test strips 1+ to 3+ haematuria; ~ trace to 2+ proteinuria
Microscopic examination dysmorphic red blood cells; red blood cell and granular casts
Blood investigations
Streptococcus serology
ASO or Anti-DNAse B titre
positive in the absence of prior antibiotic treatment
(ASO often negative in preceding skin infections)
Complement study
C3
C4

decreased
normal
Serum biochemistry
Serum electrolytes dilutional hyponatraemia, hyperchloraemic hyperkalaemic metabolic acidosis is common
Serum Urea & Creatinine mildly elevated in the acute phase
Full blood count dilutional anaemia; thrombocyte count is normal


GENERAL AND SUPPORTIVE MEASURES

  • Bed rest is necessary in children with severe hypertension or pulmonary oedema.
  • Monitor fluid balance and prescribe fluid on a daily basis:
    • Weigh daily and record fluid intake and output strictly.
    • Allowed fluid intake should be calculated based on previous day’s urine output and insensible losses.
    • In small children, fluid balance is best monitored with regular weighing.
    • Never use a potassium-containing solution in an anuric patient.
    • Do not use parenteral fluids if oral intake is possible.
  • Ensure daily fluid calculations are performed using insensible losses and previous day’s output. Fluid management according to fluid status:
    • Pulmonary oedema plus oliguria/anuria: Do not give fluid.
    • Hydrated anuric patient without extra-renal fluid losses: Oral fluid to replace insensible water losses only.
    • Normally hydrated plus oliguria: Oral fluid intake to replace insensible water loss and urine output of previous 24 hours.
    • Normally hydrated plus normal urine output: Give normal fluid intake.

IMPORTANT:
Insensible water loss is calculated as:

- Older children: 25 mL/kg/day (400 mL/m2/day)


  • Dietary measures:
    • Restrict sodium intake in all patients.
    • Restrict potassium intake until result of serum electrolytes is available.
    • Restrict protein intake to 0.5 g/kg/day.

MEDICINE TREATMENT

Eradication of streptococci:

  • Phenoxymethylpenicillin, oral, 50 mg/kg/24 hours in 4 divided doses (6 hourly) for 10 days.

OR

If unable to take oral medication:

  • Benzathine benzylpenicillin (depot formulation), IM, 30 000 units/kg/dose, 2 doses given 5 days apart.
    • Maximum dose: 1.2 million units.

For severe penicillin allergy:

Hypertension
Hypertension usually develops acutely due to fluid overload and presents as hypertension emergency (crisis), hypertension urgency or persistent significant hypertension.  See: Cardiovascular System, Hypertension in Children.

If hypertensive emergency/crisis: Patient with signs of hypertensive encephalopathy, i.e. convulsions, retinal haemorrhages, visual loss and end organ disease e.g. left heart failure.

Management for acute hypertensive emergency/crisis due to post-streptococcal glomerulonephritis:

  • Furosemide, IV, 1–2 mg/kg/dose.

If oliguric:

  • Furosemide, IV, 5 mg/kg/dose.
    • Administer IV bolus slowly over 5 minutes due to risk of ototoxicity.

AND

  • Labetalol, IV, 0.2–1.0 mg/kg/dose as a bolus.
    • Maximum bolus dose: 40 mg.
    • Continue infusion: 0.25–3.0 mg/kg/hour.
    • Monitor blood pressure frequently (every 30 minutes).
    • Taper infusion rate up or down according to response.

If hypertensive urgency: Symptomatic patients with significant elevation of blood pressure with complaints of headache, blurred vision and nausea but lack the above clinical manifestations or persistent significant hypertension:

  • Propranolol, oral, 1-2 mg/kg/dose, 6 hourly.
    • Maximum dose: 8 mg/kg/24 hours.

If blood pressure is not adequately controlled:

ADD

  • Amlodipine, oral, 0.2 mg/kg/dose.
    • May be repeated 6 hours later, thereafter once every 24 hours.
    • Maximum dose: 5 mg.
    • Crush 5 mg tablet and disperse in 5 mL water: amlodipine 1 mg/mL.

Once blood pressure has normalised, taper and stop antihypertensive treatment. Monitor blood pressure over the next 48 hours to exclude rebound hypertension.

If  volume overloaded:
See fluid management in general and supportive measures.

  • Furosemide, slow IV, 2 mg/kg/dose.
    • Maximum dose: 5 mg/kg/dose.
    • Maximum cumulative daily dose: 8 mg/kg/24 hours.

If pulmonary oedema:
See fluid management in general and supportive measures.

  • Morphine, IV, repeat after 4 hours if required
    • < 6 months of age: 0.025–0.1 mg/kg/dose.
    • ≥ 6 months of age: 0.05–0.2 mg/kg/dose.

LoEIII1

  • Oxygen, 100%, 2–3 L/minute by nasal cannula.

REFERRAL

Urgent (as soon as possible)

  • Anuric patient with acute volume overload and unresponsive to furosemide.
  • Uncontrolled hypertension.
  • Oliguric and progressive renal failure.
  • Cardiac failure or pulmonary oedema not responding to treatment.

For specialist advice

  • Macroscopic haematuria persisting for more than 4 weeks or persistent proteinuria.
  • Family history of renal disease.
  • Streptococcal aetiology unproven (ASOT and anti-DNAse B negative, normal C3 levels, decreased C4 levels).
  • Decreased complement levels which persist for more than 6 weeks.
  • Persistent renal failure after initial recovery.
  • Persistent hypertension.

Click here for the pdf. 

Click here for the Erratum-3 notice.


Standard Treatment Guidelines and Essential Medicines List for South Africa Paediatric Hospital _Chapter 6: Nephrological/Urological Disorders; 2023, 5th edition

Drugs mentioned

ICD-10 codes

NeoHealth® ID 18757 · updated 8/28/2024